Related references
Note: Only part of the references are listed.Therapeutic Hypothermia in Acute Ischemic Stroke-a Systematic Review and Meta-Analysis
Andrea M. Kuczynski et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection
Peter Ringleb et al.
INTERNATIONAL JOURNAL OF STROKE (2019)
Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
H. Ma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
G. Thomalla et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
G. W. Albers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
R. G. Nogueira et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
Mahesh Kate et al.
JOURNAL OF STROKE (2018)
Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion
E. Cortijo et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson et al.
LANCET (2014)
Wake-up stroke: clinical characteristics, imaging findings, and treatment option - an update
D. Leander Rimmele et al.
FRONTIERS IN NEUROLOGY (2014)
MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study
Maarten G. Lansberg et al.
LANCET NEUROLOGY (2012)
Perfusion-CT guided intravenous thrombolysis in patients with unknown-onset stroke: a randomized, double-blind, placebo-controlled, pilot feasibility trial
Patrik Michel et al.
NEURORADIOLOGY (2012)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
Kennedy R. Lees et al.
LANCET (2010)
Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch
T. Chemmanam et al.
NEUROLOGY (2010)
MR Imaging Helps Predict Time from Symptom Onset in Patients with Acute Stroke: Implications for Patients with Unknown Onset Time
Mina Petkova et al.
RADIOLOGY (2010)
Negative Fluid-Attenuated Inversion Recovery Imaging Identifies Acute Ischemic Stroke at 3 Hours or Less
Goetz Thomalla et al.
ANNALS OF NEUROLOGY (2009)
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study
Werner Hacke et al.
LANCET NEUROLOGY (2009)
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial
Stephen M. Davis et al.
LANCET NEUROLOGY (2008)
Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
Nils Wahlgren et al.
LANCET (2007)
Established treatments for acute ischaemic stroke
Aslam M. Khaja et al.
LANCET (2007)
Share Paper
